Cardiovascular Systems Stock Target Price
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Cardiovascular Systems' long-term financial health and intrinsic value.
Cardiovascular |
Cardiovascular Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardiovascular Systems' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardiovascular Systems could also be used in its relative valuation, which is a method of valuing Cardiovascular Systems by comparing valuation metrics of similar companies.Cardiovascular Systems is currently under evaluation in target price category among its peers.
Cardiovascular Fundamentals
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X | |||
| Price To Book | 2.43 X | |||
| Price To Sales | 2.51 X | |||
| Revenue | 236.22 M | |||
| Gross Profit | 172.78 M | |||
| EBITDA | (29.96 M) | |||
| Net Income | (36.93 M) | |||
| Cash And Equivalents | 159.83 M | |||
| Cash Per Share | 3.90 X | |||
| Total Debt | 22.15 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 6.05 X | |||
| Book Value Per Share | 5.70 X | |||
| Cash Flow From Operations | (24.27 M) | |||
| Short Ratio | 2.66 X | |||
| Earnings Per Share | (0.96) X | |||
| Price To Earnings To Growth | 177.27 X | |||
| Target Price | 16.75 | |||
| Number Of Employees | 725 | |||
| Beta | 0.74 | |||
| Market Capitalization | 843.96 M | |||
| Total Asset | 322.68 M | |||
| Retained Earnings | (320 M) | |||
| Working Capital | 69.38 M | |||
| Current Asset | 104.88 M | |||
| Current Liabilities | 35.5 M | |||
| Z Score | 22.8 | |||
| Net Asset | 322.68 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |